Osimertinib in lung cancer: added benefit not proven supriya kashyap kashyap22 Jun 2016 2:55 PM ISTOsimertinib has been approved since February 2016 for the treatment of adult patients with locally advanced or metastatic epidermal growth factor...
Study indicate towards new therapy for hearing loss Medha Baranwal Baranwal20 Oct 2018 7:05 PM ISTLoss of cochlear hair cells leads to permanent hearing deficits, and once lost, the cells are not regenerated. In a new study, published in the...
Addition of diabetes drug Metformin improves survival in lung cancer patients: JAMA Oncology Medha Baranwal Baranwal20 Sept 2019 7:10 PM ISTMexico: The diabetes drug metformin apart from lowering blood sugar in type 2 diabetes patients has been previously shown to have varied benefit in...
Bowel cancer: New function of known biomarkers discovered supriya kashyap kashyap14 April 2017 11:41 AM ISTEGFR (Epidermal Growth Factor Receptors) are involved in the development and progression of many types of cancer and bowel cancer (colon carcinoma) in...
